Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07194070 · ClinicalTrials.gov registry record
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
A clinical trial of Hemolytic Disease of the Fetus and Newborn, sponsored by Janssen Research & Development.
- Recruiting
- Registry status
- 175
- Enrollment target
- 10
- Study locations
NCT07194070 is a study of Hemolytic Disease of the Fetus and Newborn that is actively recruiting participants, run by Janssen Research & Development. The registered enrollment target is 175 participants. The trial reports 10 study locations across 5 states.
The verdict
NCT07194070, a study of Hemolytic Disease of the Fetus and Newborn, is actively recruiting participants, sponsored by Janssen Research & Development.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this non-interventional study is to prospectively evaluate the risk of anemia (decreased red blood cells) in fetuses (baby before birth) and neonates (baby just after birth) of pregnant participants who are at risk for hemolytic disease of the fetus and newborn (HDFN) and receiving standard of care (SoC). HDFN is a blood disease that occurs in babies before birth or just after birth when the blood types of the pregnant individual and babies are incompatible, thus resulting in fast breakdown of red blood cells (RBCs) of the fetus/baby.
Conditions Studied
Interventions
- OTHER Standard of Care
Study Locations (10)
Other
- The Royal Women's Hospital - Parkville
- Mater Misericordiae Ltd - South Brisbane
- Interdiszip Schwerpunkt fur Hamostaseologie - Giessen
- Mangiagalli Clinic IRCCS Ca Granda Foundation Ospedale Maggiore Policlinico - Milan
- Fondazione Policlinico Universitario A Gemelli IRCCS - Roma
- Birmingham Women's Hospital - Birmingham
Indiana
- Riley Children s Hospital - Indianapolis
Ohio
- University of Cincinnati - Cincinnati
Oregon
- Oregon Health And Science University - Portland
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2030-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07194070
The ClinicalTrials.gov registry entry for NCT07194070 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemolytic Disease of the Fetus and Newborn appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care is the first listed.
NCT07194070 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Other, Indiana, Ohio.
Frequently Asked Questions
What is clinical trial NCT07194070 about?
NCT07194070 is a clinical study titled "A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry". The purpose of this non-interventional study is to prospectively evaluate the risk of anemia (decreased red blood cells) in fetuses (baby before birth) and neonates (baby just after birth) of pregnant participants who are at risk for hemolytic disease of the fetus and newborn (HDFN) and receiving st...
What is the current status of trial NCT07194070?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2025-02-20. Estimated completion is 2030-09-30.
What conditions does trial NCT07194070 study?
This clinical trial studies the following conditions: Hemolytic Disease of the Fetus and Newborn.
What interventions are being tested in trial NCT07194070?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT07194070?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07194070 being conducted?
This trial has 10 study locations across Indiana, Ohio, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemolytic Disease of the Fetus and Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.